Drug intelligence / Profile preview

silybin phospholipid complex

Development stage
Unknown
Lead developer
Gnosis
Modality
Small Molecules, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
Administration
Oral
01

Overview

Silybin phospholipid complex is a formulation that combines silybin—the most active and abundant flavonolignan component of the milk thistle extract (silymarin)—with phospholipids (typically phosphatidylcholine) to enhance its oral bioavailability and therapeutic efficacy. Silybin itself has poor water and oil solubility, resulting in low absorption when taken orally. Complexing it with phospholipids increases its lipophilicity, allowing for improved passage across cell membranes and better systemic absorption[1][3][5]. The primary mechanism of action is hepatoprotection through antioxidant, anti-inflammatory, cytoprotective effects, as well as modulation of mitogenic signaling pathways involved in liver health[4]. This formulation is used mainly to support liver function in conditions such as nonalcoholic fatty liver disease (NAFLD), chronic hepatitis C infection (especially when conventional antiviral therapy cannot be used), alcoholic liver disease, cirrhosis, and other forms of toxic or metabolic liver injury[6][8]. Clinical studies have shown benefits including reduction in markers of oxidative stress and inflammation; improvement in hepatic enzyme levels; decreased fibrosis progression; and enhanced glutathione production. Silybin-phospholipid complexes are available under various brand names for use as dietary supplements or adjunctive therapies.

Brand names
Phosphocomplex
Other names
silybin–phosphatidylcholine complexSilPhosilybin-phospholipid phytosomesilybin-PC complex

Beyond the preview

Go deeper on silybin phospholipid complex.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on silybin phospholipid complex.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call